Pharmaceutical - Respiratory and Pulmonary


Current filters:

Respiratory and Pulmonary

Popular Filters

201 to 225 of 304 results

SkyePharma partner Kyorin files for Flutiform approval in Japan


UK drug delivery specialist SkyePharma (LSE: SKP) says that its Japanese development and marketing partner…

Asia-PacificFlutiformKyorin PharmaceuticalsNapp PharmaceuticalsPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

SkyePharma/Mundipharma's Flutiform launched in Germany


UK-based drug delivery specialist SkyePharma (LSE: SKP) last Friday announced the launch of Flutiform,…

EuropeFlutiformMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

Denmark sees first launches of Almirall's Eklira Genuair and ViroPharma's Plenadren


Spain's largest drugmaker, Almirall (ALM: MC), says that the Danish Health and Medicines Authority has…

AlmirallEklira GenuairEuropeMarkets & MarketingPharmaceuticalPlenadrenRare diseasesRespiratory and PulmonaryViroPharma

Unigene and Tarix report highly increased oral bioavailability of "Peptelligence-engineered" TXA127


USA-based Unigene Laboratories Laboratories (OTCBB: UGNE) and Tarix Pharmaceuticals yesterday announced…

Cardio-vascularLicensingPharmaceuticalResearchRespiratory and PulmonaryTarix PharmaceuticalsTXA127Unigene Labs

French price regulator authorizes reimbursement of InterMune's Esbriet


USA-based InterMune (Nasdaq: ITMN) says that French regulator the Comite Economique des Produits de…

EsbrietEuropeInterMunePharmaceuticalPricingRespiratory and Pulmonary

Almirall sets up first direct North America presence


Almirall (ALM: MC), Spain's largest pharmaceutical company, says it has set up a new affiliate in Canada…

aclidiniumAlmirallMarkets & MarketingNorth AmericaPharmaceuticalRespiratory and Pulmonary

Boehringer reveals new data on olodaterol and tiotropium combo at ERS


German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Almirall says Eklira Genuair provides meaningful and sustained bronchodilation from the first dose


Spain's largest drugmaker, Almirall (ALM: MC) yesterday announced positive results for two Phase IIIb…

AlmirallEklira GenuairPharmaceuticalResearchRespiratory and Pulmonary

New data from Novartis on QVA149 and Seebri Breezhaler at ERS


Further data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs…

NovartisPharmaceuticalQVA149ResearchRespiratory and PulmonarySeebri BreezhalerVectura

Sunovion to acquire Elevation Pharma for up to $430 million


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506) last week…

Dainippon Sumitomo PharmaElevation PharmaceuticalsEP-101Mergers & AcquisitionsPharmaceuticalRespiratory and PulmonarySunovion

FDA warns against use of Pfizer's Revatio in children with PAH


The US Food and Drug Administration is recommending that Revatio (sildenafil), marketed by US drugs behemoth…

North AmericaPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatiosildenafil

Novartis set to file QVA149 filing in EU and Japan by end of year


Swiss drug major Novartis announced yesterday that the fifth QVA149 (indacaterol maleate/glycopyrronium…

NovartisPharmaceuticalQVA149RegulationResearchRespiratory and PulmonarySeebri BreezhalerVectura

Boehringer's Spiriva has advantages for patients with COPD, says IQWiG


In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD),…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and PulmonarySpiriva

GSK completes LAMA/LABA Ph III program; readies for global filings


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) say they have completed…

GlaxoSmithKlinePharmaceuticalRegulationResearchRespiratory and PulmonaryTheravanceumeclidiniumvilanterol

Flutiform receives UK regulatory approval; solid financials from SkyePharma


UK-based drug delivery specialist SkyePharma (LSE: SKP) yesterday announced that the UK the Medicines…

FinancialFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Credit Suisse focus on new drugs for COPD


New data will be presented at the European Respiratory Society, due to take place in Vienna, Austria,…

aclidiniumAlmirallGlaxoSmithKlineNovartisPharmaceuticalQVA149ResearchRespiratory and PulmonaryTheravanceVecturaZephyr

Vectura updates on developmental products and milestones


UK-based Vectura (LSE: VEC) saw its share price rise 4.9% to 75.50 pence yesterday morning, after the…

FinancialPharmaceuticalResearchRespiratory and PulmonarySeebri BreezhalerVectura

Shionogi partner Ildong gains South Korean approval for Pirespa


Japanese drug major Shionogi (TYO: 4507) says that its South Korean partner Ildong Pharma has received…

Asia-PacificIldong PharmaPharmaceuticalPirespapirfenidoneRegulationRespiratory and PulmonaryShionogi

Salix and Alfa Wassermann expand rifaximin accord


USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive…

Alfa WassermannGastro-intestinalsLicensingPharmaceuticalRespiratory and PulmonaryrifaximinSalix Pharmaceuticals

Positive outlook for Vectura, as Seebri Breezhaler closer to EU approval


UK-based inhalation product development company Vectura (LSE: VEC) is a step closer to European approval…

FinancialNovartisPharmaceuticalRegulationRespiratory and PulmonarySeebri BreezhalerVectura

ALK Abello partner Torii progresses Japanese development of Mitizax


Denmark-based allergy specialist ALK Abello (ALKB: DC) revealed yesterday that its strategic partner,…

ALK AbelloImmunologicalsMitizaxPharmaceuticalResearchRespiratory and PulmonaryTorii Pharma

New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck


New Zealand's Pharmaceutical Management Agency PHARMAC is to fund a treatment for pre-schoolers with…

Asia-PacificDermatologicalsHealthcareMerck & CoPharmaceuticalPricingRespiratory and PulmonarySingulairStromectil

Lupin in deal to market Novartis' Onbrez in India, local newspaper reports


Indian drugmaker Lupin Pharmaceuticals (LOPN: BO) and Swiss major Novartis (NOVN: VX) have entered into…

Asia-PacificLicensingLupinMarkets & MarketingNovartisOnbrezPharmaceuticalRespiratory and Pulmonary

Almirall's aclidinium approved in Europe for COPD maintenance treatment


Spain's leading drugmaker, Almirall (ALM: MC) says that the European Commission has granted marketing…

aclidiniumAlmirallBretaris GenuairEklira GenuairEuropeMenariniPharmaceuticalRegulationRespiratory and Pulmonary

201 to 225 of 304 results

Back to top